DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA. Mediterr J Hematol Infect Dis 2019, 11 (1), e2019016. https://doi.org/10.4084/mjhid.2019.016.